Correlation Between Day One and Innoviva

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Day One and Innoviva at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Innoviva into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Innoviva, you can compare the effects of market volatilities on Day One and Innoviva and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Innoviva. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Innoviva.

Diversification Opportunities for Day One and Innoviva

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Day and Innoviva is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Innoviva in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innoviva and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Innoviva. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innoviva has no effect on the direction of Day One i.e., Day One and Innoviva go up and down completely randomly.

Pair Corralation between Day One and Innoviva

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Innoviva. In addition to that, Day One is 2.29 times more volatile than Innoviva. It trades about -0.1 of its total potential returns per unit of risk. Innoviva is currently generating about -0.07 per unit of volatility. If you would invest  1,936  in Innoviva on September 3, 2024 and sell it today you would lose (37.00) from holding Innoviva or give up 1.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Day One Biopharmaceuticals  vs.  Innoviva

 Performance 
       Timeline  
Day One Biopharmaceu 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Day One Biopharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Innoviva 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Innoviva has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Innoviva is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Day One and Innoviva Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Day One and Innoviva

The main advantage of trading using opposite Day One and Innoviva positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Innoviva can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innoviva will offset losses from the drop in Innoviva's long position.
The idea behind Day One Biopharmaceuticals and Innoviva pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Stocks Directory
Find actively traded stocks across global markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments